We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $92M
1-Year Est. Return 25.18%
This Fund
S&P 500
This Quarter Est. Return
+8.32%
1 Year Est. Return
+25.18%
3 Year Est. Return
+50.89%
5 Year Est. Return
+36.12%
10 Year Est. Return
AUM
$89.5M
AUM Growth
+$2.59M
Cap. Flow
-$3.19M
Cap. Flow %
-3.56%
Top 10 Hldgs %
76.74%
Holding
52
New
7
Increased
16
Reduced
19
Closed
9
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$227B
$361K 0.4%
891
+367
+70% +$153K
EW icon
27
Edwards Lifesciences
EW
$51.8B
$348K 0.39%
4,445
-526
-11% -$39.2K
INCY icon
28
Incyte
INCY
$25.9B
$347K 0.39%
5,094
+1,724
+51% +$109K
PFE icon
29
Pfizer
PFE
$162B
$325K 0.36%
13,428
+4,777
+55% +$111K
UWM icon
30
ProShares Ultra Russell2000
UWM
$248M
$298K 0.33%
7,907
+20
+0.3% +$662
TIP icon
31
iShares TIPS Bond ETF
TIP
$15B
$270K 0.3%
2,452
-522
-18% -$56.9K
REGN icon
32
Regeneron Pharmaceuticals
REGN
$85.6B
$257K 0.29%
+490
New +$273K
HYG icon
33
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$257K 0.29%
+3,183
New +$251K
PM icon
34
Philip Morris
PM
$285B
$257K 0.29%
1,413
+12
+0.9% +$2.06K
IGF icon
35
iShares Global Infrastructure ETF
IGF
$10.4B
$231K 0.26%
3,905
-2,903
-43% -$166K
UNH icon
36
UnitedHealth
UNH
$356B
$229K 0.26%
734
-86
-10% -$32.9K
LQD icon
37
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.5B
$216K 0.24%
+1,975
New +$212K
ZURA icon
38
Zura Bio
ZURA
$583M
$67.2K 0.08%
63,985
-44,323
-41% -$53K
ANNX icon
39
Annexon
ANNX
$919M
$66.2K 0.07%
27,575
-1,016
-4% -$2.04K
CTMX icon
40
CytomX Therapeutics
CTMX
$789M
$62.9K 0.07%
27,698
-72,372
-72% -$117K
MREO
41
Mereo BioPharma
MREO
$41.6M
$51.9K 0.06%
19,138
-28,492
-60% -$68.8K
GERN icon
42
Geron
GERN
$983M
$49.6K 0.06%
35,181
-27,792
-44% -$39.4K
NKTX icon
43
Nkarta
NKTX
$208M
$46.4K 0.05%
27,979
-1,212
-4% -$2.22K
BKLN icon
44
Invesco Senior Loan ETF
BKLN
$6.73B
-9,786
Closed -$203K
COGT icon
45
Cogent Biosciences
COGT
$6.02B
-14,015
Closed -$83.5K
DJP icon
46
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$875M
-6,120
Closed -$216K
IEF icon
47
iShares 7-10 Year Treasury Bond ETF
IEF
$42.1B
-2,196
Closed -$209K
IMTX icon
48
Immatics
IMTX
$1.44B
-15,971
Closed -$71.8K
ITOS
49
DELISTED
iTeos Therapeutics
ITOS
-11,061
Closed -$66.4K
LEGN icon
50
Legend Biotech
LEGN
$4.18B
-6,429
Closed -$219K

Similar funds

Forefront Analytics's Q2 2025 Portfolio in Review

As of Q2 2025, Forefront Analytics held 52 positions worth $89.5M, up 3% from $86.9M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Forefront Analytics withdrew a net $3.19M in Q2 2025, closing 9 positions and reducing 19 holdings. Its most notable exit was State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF, an estimated $9.33M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Forefront Analytics opened a new position in iShares ESG Aware MSCI EAFE ETF worth $6.49M.

  • Forefront Analytics's largest Q2 2025 buy was iShares ESG Aware MSCI EAFE ETF: 72,693 shares worth $6.49M.
  • Forefront Analytics added most to Vanguard Morningstar Small-Cap ETF in Q2 2025, an estimated $1.17M increase.
  • Forefront Analytics's biggest Q2 2025 reduction was Nuveen ESG Large-Cap Value ETF, cutting an estimated $8.32M.
  • Forefront Analytics fully exited State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF in Q2 2025, selling an estimated $9.33M.
  • Forefront Analytics's ten largest holdings make up 77% of its $89.5M portfolio in Q2 2025.
  • Forefront Analytics opened 7 new positions and closed 9 in Q2 2025.
  • Forefront Analytics's portfolio value rose 3% quarter-over-quarter to $89.5M.

Based on Forefront Analytics's 13F filing for Q2 2025, filed 24 Jul 2025.